Provider review
Layla review
Three tirzepatide prices on one page, and no milligram figure on any of them.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$297/mo semaglutide, $399 tirzepatide (a third block says $449)
Visit LaylaNothing here attaches a dose to a price, so the low-dose question cannot be answered before you pay. The month-to-month tirzepatide rate appears twice on the same page at two different figures. And a card badged cancel-anytime sits above a policy demanding thirty days' notice.
Price as published
Layla
$297/mo semaglutide, $399 tirzepatide (a third block says $449)
- Vs median
- $122/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
You cannot find out what a quarter dose costs at Layla, because no milligram figure appears against any price on any page. What you can find is disagreement: the same page prices month-to-month tirzepatide two different ways, and its own FAQ quotes a starting cost matching no card on the site. Give Layla credit for one genuinely useful habit — it prints the pre-discount monthly rate in parentheses beside every first-month offer, so the standing rate sits next to the teaser instead of hiding behind it. Then read the small print, because it costs you. Every plan is badged cancel-anytime while the refund policy on the same page requires thirty days' notice. Canceling costs a non-refundable visit and clinical fee out of your refund. And the all-treatments page stamps the same monthly figure on every product, including the brand-name drugs it cannot apply to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the standing rate visible beside the first-month offer rather than hidden behind it.
- You already know the dose you want and do not need it priced.
Look elsewhere if
- You are taking less to spend less. No dose is published against any price here, so there is nothing to work with.
- You are budgeting tirzepatide month to month. Two different standing rates appear on the same page.
- You read cancel-anytime as cancel-today. The policy on the same page asks for thirty days' notice.
- You expect a full refund if you stop. A non-refundable visit and clinical fee comes out of it.
- You want the dispensing pharmacy named, or your state confirmed before you order.
What it actually costs
Price as published
$297/mo semaglutide, $399 tirzepatide (a third block says $449)
- Vs median
- $122/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Publishes no milligram figure against any price on any page, so there is no way to tell whether the price follows the dose. The prices themselves disagree — two different month-to-month tirzepatide rates on one page, and a FAQ figure matching no card. One genuinely useful habit: the pre-discount monthly rate is printed beside every first-month offer, so you can see the standing price even where you cannot see the dose.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Publishes the pre-discount month-to-month rate in parentheses beside every first-month offer — "Starting at $197 / 1st Month (Originally $297 / month)" — so the standing rate is at least visible next to the teaser
- States a refund policy with an explicit cancellation fee on the pricing page rather than leaving it to the terms page
- Prices both molecules on monthly and quarterly plans openly, with no intake gate
Pharmacy, labs and oversight
Layla does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Layla publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Layla sells compounded semaglutide and compounded tirzepatide as weekly injections on monthly and quarterly plans, advertised as all-inclusive of prescription, medication and shipping. Prices are published openly, with the pre-discount monthly rate shown in parentheses beside each first-month offer. Brand-name products are listed on a separate all-treatments page. No milligram figure appears against any price anywhere on the site, and no compounding pharmacy is named.
The honest cons
NOT ONE MILLIGRAM FIGURE APPEARS AGAINST ANY PRICE on /weight-loss or /all-treatments, so what a low dose costs cannot be established before paying
- THREE PRICE BLOCKS ON ONE PAGE DISAGREE. Month-to-month tirzepatide is $449 in one block and $399 in another
- The FAQ on the same page states "The starting cost for GLP-1 medication starts at $1299", a figure that matches no price card on the site
- "CANCEL ANY-TIME" IS BADGED ON EVERY CARD while the refund policy on the same page reads "Subscriptions can be canceled at any time. - Please provide a 30-day notice for cancellation"
- Canceling costs money: "If the order is successfully canceled, a $100 nonrefundable visit and clinical fee will be deducted from your refund"
- On /all-treatments, Wegovy is listed at $1699 and Mounjaro at $1399 while each card is also stamped "$297/mo" — the same field repeated on every row
- Outcome statistics are sourced to "Layla clinical care data of over 1000 patientes over the last 12 months" [sic]
- No compounding pharmacy is named — only "a partner pharmacy"
- States served are not published
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Layla is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Layla does. Both are partners: we may earn a commission if you start care through these links.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Partner
Direct Meds
From $249/mo sublingual · $297/mo injection
Standard plan, self-directed low dose
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
Where this sits
#93 of 548
Ordered with the companies that pay us first, and Layla is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.